Provention Bio, Inc. Business Finance Contracts & Agreements
27 Contracts & Agreements
- Escrow Agreements (1 contract)
- Loan Agreements (2)
- Purchase Agreements (7)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Subscription Agreements (3)
- Underwriting Agreements (5)
- Warrant Agreements (6)
- First Amendment to Loan and Security Agreement, dated February 2, 2023, between Provention Bio, Inc. and Hercules Capital Inc. (, Exhibit 10.30) (Filed With SEC on March 29, 2023)
- Amendment No. 1 to the Asset Purchase Agreement between Provention Bio, Inc. and MacroGenics, Inc., dated November 30, 2022 (, Exhibit 10.29) (Filed With SEC on March 29, 2023)
- Warrant Agreement, dated February 2, 2023, issued by Provention Bio, Inc. (, Exhibit 4.6) (Filed With SEC on March 29, 2023)
- Securities Purchase Agreement, dated October 4, 2022, between Provention Bio, Inc. and Aventis Inc (Filed With SEC on March 24, 2023)
- Loan and Security Agreement, dated August 31, 2022, between Provention Bio, Inc. and Hercules Capital, Inc. (, Exhibit 10.1) (Filed With SEC on November 3, 2022)
- Warrant Agreement, dated September 15, 2022, issued by Provention Bio, Inc. (, Exhibit 4.1) (Filed With SEC on November 3, 2022)
- Form of Purchase Agreement, dated as of July 7, 2022, among Provention Bio, Inc. and each Purchaser party thereto (Filed With SEC on July 8, 2022)
- Form of Warrant to Purchase Stock, dated as of July 7, 2022, issued by Provention Bio, Inc (Filed With SEC on July 8, 2022)
- Form of Stock Option Award under Provention Bio, Inc. 2020 Inducement Plan (, Exhibit 10.1) (Filed With SEC on May 6, 2021)
- Underwriting Agreement, dated January 13, 2021, among Provention Bio, Inc. and SVB Leerink LLC and Cantor Fitzgerald & Co., as representatives of the several underwriters (Filed With SEC on January 15, 2021)
- Underwriting Agreement, dated June 17, 2020, by and among Provention Bio, Inc. and SVB Leerink LLC and Cantor Fitzgerald & Co., as representatives of the underwriters (Filed With SEC on June 18, 2020)
- Subscription Agreement, dated September 18, 2019, by and between Provention Bio, Inc. and Amgen, Inc (Filed With SEC on September 19, 2019)
- Underwriting Agreement, dated September 18, 2019, by and between Provention Bio, Inc. and SVB Leerink LLC, as representative of the underwriters (Filed With SEC on September 19, 2019)
- Form of Subscription Agreement with Amgen, Inc (Filed With SEC on June 10, 2019)
- Form of Underwriting Agreement (Filed With SEC on June 10, 2019)
- Form of Escrow Deposit Agreement for the offering (Filed With SEC on June 20, 2018)
- Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 20, 2018)
- Specimen Certificate representing shares of common stock of Provention (Filed With SEC on June 20, 2018)
- Form of Subscription Agreement for the offering (Filed With SEC on June 12, 2018)
- Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 12, 2018)
- Form of Underwriters Warrant (Filed With SEC on June 12, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 12, 2018)
- Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on May 16, 2018)
- Form of Warrant dated May 7, 2018, issued to MacroGenics, Inc (Filed With SEC on May 16, 2018)
- Form of Registration Rights Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)
- Form of Securities Purchase Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)
- Form of Warrant dated April 25, 2017, issued to MDB Capital Group, LLC (Filed With SEC on May 9, 2018)
